GRAL logo

GRAIL Inc. (GRAL)

$105.88

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on GRAL

Market cap

$4.76B

EPS

-9.43

P/E ratio

--

Price to sales

50.44

Dividend yield

--

Beta

2.867055

Price on GRAL

Previous close

$105.60

Today's open

$108.95

Day's range

$99.52 - $110.56

52 week range

$41.50 - $166.48

Profile about GRAL

CEO

Bob Ragusa

Employees

910

Headquarters

Sunnyvale, CA

Exchange

Nasdaq Global Select

Shares outstanding

44962171

Issue type

Common Stock

GRAL industries and sectors

Healthcare

Medical Diagnostics & Screening

News on GRAL

GRAIL, Inc. (GRAL) Presents at 2026 UBS Global Healthcare Conference Transcript

GRAIL, Inc. ( GRAL ) 2026 UBS Global Healthcare Conference November 10, 2026 11:00 AM EST Company Participants Aaron Freidin - CFO & Head of Corporate Development Conference Call Participants Douglas Schenkel - UBS Investment Bank, Research Division Presentation Douglas Schenkel UBS Investment Bank, Research Division All right. Good morning.

news source

Seeking Alpha • Nov 10, 2026

news preview

GRAIL Q3 Earnings Call Ties FDA Review to Pricing and Sales Growth

GRAL is cutting Galleri prices to boost adoption ahead of an expected early 2027 FDA decision, even as pricing pressure weighs on revenue growth and margins.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Artisan Global Equity Fund Q3 2026 Portfolio Review

In Q3 2026, the portfolio underperformed its benchmark, the MSCI All Country World Index. On a positive note, our stock selection in the health care sector led to significant outperformance relative to those in the benchmark. Numerous portfolio moves were made during the quarter, but our focus remained on our three main investment themes: electrification, financials and aerospace and defense.

news source

Seeking Alpha • Nov 5, 2026

news preview

Grail Tumbles After DNA-Testing Outfit Misses Sales Expectations

Grail stock fell late Wednesday after the next-generation sequencing company reported light third-quarter sales.

news source

Investors Business Daily • Nov 4, 2026

news preview

What GRAIL (GRAL) Said on Its Q3 Earnings Call

GRAIL NASDAQ: GRAL reported 4% revenue growth for the third quarter of 2026 as higher testing volumes were offset in part by lower prices, and said it expects a U.S. regulatory decision on its Galleri cancer screening test by early in the first quarter of 2027.

news source

MarketBeat • Nov 5, 2026

news preview

GRAIL, Inc. (GRAL) Q3 2026 Earnings Call Transcript

GRAIL, Inc. (GRAL) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

GRAIL Reports Third Quarter 2026 Financial Results

FDA Advisory Committee Voted in Favor of Approval of GRAIL's Galleri Multi-Cancer Early Detection Test Q3 Galleri ® Test Volume Increased ~24% to More Than 56,000 Year-Over-Year, Year-to-Date Test Volume Increased ~36% to More Than 174,000 Q3 Galleri Revenue Grew 14% Year-Over-Year to $37.3 Million SUNNYVALE, Calif., Nov. 4, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter of 2026.

news source

PRNewsWire • Nov 4, 2026

news preview

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth

GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection.

news source

Zacks Investment Research • Oct 29, 2026

news preview

GRAIL to Present at the UBS Global Healthcare Conference

SUNNYVALE, Calif., Oct. 27, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the UBS Global Healthcare Conference in Palm Beach, FL on Tuesday, Nov. 10 at 11:00 a.m.

news source

PRNewsWire • Oct 27, 2026

news preview

5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps

The S&P 500 recently sat just 2.5% below its all-time high. Look past the index, though, and the picture gets uglier.

news source

MarketBeat • Oct 26, 2026

news preview

¹ Disclosures

Get started with M1

Invest in GRAIL Inc.

Open an M1 investment account to buy and sell GRAIL Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in GRAL on M1